Skip to main content
user-generated· Science

Will Replimune resubmit its drug application for RP1 to the FDA by De…

Market overview

The headline indicates Replimune's intention to resubmit its drug application. Given the FDA shakeup, they likely want to act relatively quickly to capitalize on the new environment. However, preparing a comprehensive resubmission can take time.

Science prediction market

Implied probability (Yes)
80%
Closes
2029-08-27

More Science markets

Browse all Science markets →

Loading…